YORVIPATH DIN 02565161
Health Canada record
| Active ingredient(s) | PALOPEGTERIPARATIDE 294 MCG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | |
| Original market date | 10-Apr-2026 |
| Current status date | 10-Apr-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PALOPEGTERIPARATIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02565153 | YORVIPATH | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | PALOPEGTERIPARATIDE 168 MCG | Approved |
| 02565188 | YORVIPATH | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | PALOPEGTERIPARATIDE 420 MCG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36796 | 2026-01-28 | New Drug Submission (NDS) |